Nanoparticle Strategies for Treating CNS Disorders
Author Information
Author(s): Toader Corneliu, Dumitru Adrian Vasile, Eva Lucian, Serban Matei, Covache-Busuioc Razvan-Adrian, Ciurea Alexandru Vlad, Agalakova Natalia I.
Primary Institution: Department of Neurosurgery, “Carol Davila” University of Medicine and Pharmacy
Hypothesis
Nanoparticle technologies can effectively address the challenges of drug delivery and diagnostics in central nervous system disorders.
Conclusion
Nanoparticle technologies show promise in improving drug delivery and diagnostic capabilities for CNS disorders, potentially enhancing patient outcomes.
Supporting Evidence
- Nanoparticles can cross the blood-brain barrier to deliver medications directly to targeted CNS regions.
- Recent advancements in nanoparticle technologies offer promising solutions for drug delivery and neuroprotection.
- Studies indicate that nanoparticles may improve drug delivery and minimize side effects in models of Alzheimer's and Parkinson's diseases.
Takeaway
Scientists are using tiny particles called nanoparticles to help deliver medicine to the brain better and to find brain problems earlier.
Methodology
This review examines current research on nanoparticle technologies and their applications in CNS disorders.
Limitations
The review does not provide specific experimental data or sample sizes, limiting the ability to assess the strength of the evidence presented.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website